🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

It’s an incredible honour to have been elected to the Royal Society of Canada College of New Scholars! Humbling to join such accomplished colleagues from McMaster University and across the country

COVID-19 is surging again, driven by highly contagious Omicron sub-variants. Miller Lab tells National Post that while the virus is evolving unpredictably, current vaccines still offer protection against severe infections, hospitalization, and death. nationalpost.com/health/what-to…

HERC is perfectly aligned with our mission to drive impact through collaboration between academia, government, industry, and public health. As co-lead of a federally-funded pandemic preparedness hub (CP2H), we look forward to supporting ISED's growing life sciences strategy.

Jakob Magolan, part of our executive team, is collaborating with neurobiologists on a new therapeutic approach to preventing cancer from spreading to the brain. healthsci.mcmaster.ca/mcmaster-chemi…

Matthew Miller (Miller Lab), director McMaster IIDR and Global Nexus, spoke with Ottawa Citizen about COVID-19 and the general need for mucosal vaccines—next-generation vaccines that are needle-free and can be sprayed or inhaled. ow.ly/abqt50TIWfO

Efficiently moving new drugs from academic labs to the patients who need them is mission-critical at Global Nexus. Here, researchers Jakob Magolan and Sheila Singh discuss how they're working together to bring important new cancer drugs to market. healthsci.mcmaster.ca/fly-on-the-wal…

.Global Nexus researchers collaborate to shorten the long & winding road to drug discovery. Jakob Magolan & Sheila Singh (Sheila Singh Brain Tumour Lab) on their unique approach to developing a new anti-cancer medicine. 👇 McMaster Biochemistry & Biomedical Sciences McMaster Surgery Centre for Discovery in Cancer Research ow.ly/rkuc50TQSVv

A McMaster University-affiliated biotech is expanding to McMaster Innovation Park, where it will intensify its drug discovery efforts with new assets, talent, and tech. 👇 ow.ly/aibR50TWusF

Meet Matthew Miller, Director of the IIDR and Global Nexus. He's working on pandemic prevention measures, like vaccines and therapeutics, that provide protection against large viral families. Today, Miller Lab will be inducted into the RSC // SRC's College of New Scholars!

Meet Dr. Matthew Miller, Executive Director at McMaster University ’s Global Nexus & McMaster IIDR , focused on pandemic prevention and groundbreaking vaccines. He will be moderating the Biomanufacturing panel at #NGBi2024 on November 12th at the Hamilton Convention Center. Head to

From transmission to symptoms, what to know about avian flu after B.C. case. Matthew Miller (Miller Lab), director McMaster IIDR & Global Nexus, spoke with The Canadian Press News about the symptoms of H5N1 and how it differs from seasonal flu. ow.ly/Puq550U5cVA

Global Nexus and McMaster IIDR director Miller Lab moderated the biomanufacturing panel at the NGBideas 🇨🇦 summit today. The panel featured a quartet of top life sciences experts from across Canada. #NGBiSummit

We are so grateful for the support from McMaster HealthLabs. This funding will enable critical translation activities that will bring health discoveries closer to the patients who need them. #NationalPhilanthropyDay healthsci.mcmaster.ca/mcmaster-affil…

A great day to welcome Filomena Tassi to campus to announce $4M via FedDev Ontario for our Centre for Collaborative Chemistry (C3). Thank you! McMaster is better positioned than ever to help get new therapies to market. ow.ly/UCi150UhIFL

The Government of Canada announced today a $4M investment in Global Nexus, which will be leveraged for bold new drug discovery and development initiatives at McMaster. healthsci.mcmaster.ca/government-of-…

We’re pleased to support McMaster University’s new Centre for Collaborative Chemistry (C3) with a $4M investment! C3 will fast-track the development and commercialization of life-changing medications—improving the lives of Canadians, creating jobs, and growing our life-sciences sector.

Transformative investment of $4M from FedDev for the Centre for Collaborative Chemistry at McMaster University. The C3 will be an anchor tenant for Global Nexus and other research hubs McMaster University and McMaster Biochemistry & Biomedical Sciences for made-in-Canada drug products. chch.com/chch-news/fedd…

New from @Macleans: How Jon Stokes is working at the intersect of academia and industry to get new antibiotics to the finish line faster. macleans.ca/society/health…

McMaster University remains one of Canada’s top research universities, based on the annual rankings published today by Research Infosource. #CIL2024 McMaster University earned the top spot for research income growth and for graduate student research intensity. brighterworld.mcmaster.ca/articles/mcmas…

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being developed in Hamilton after a McMaster University researcher discovered a new fungal compound that could improve brain health. thespec.com/news/hamilton-…